Knowledge of hepatitis among active drug injectors at a syringe exchange program

Injecting drug users (IDUs) are at high risk for contracting and spreading viral hepatitis through nonsterile injection practices, unprotected sexual contact, and unsanitary living conditions. We sought to characterize hepatitis knowledge, prior testing, and vaccination history among IDUs at a New Y...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of substance abuse treatment 2005-07, Vol.29 (1), p.47-53
Hauptverfasser: Carey, Jeanne, Perlman, David C., Friedmann, Patricia, Kaplan, Wendy M., Nugent, Ann, Deutscher, Meredith, Masson, Carmen L., Des Jarlais, Don C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 53
container_issue 1
container_start_page 47
container_title Journal of substance abuse treatment
container_volume 29
creator Carey, Jeanne
Perlman, David C.
Friedmann, Patricia
Kaplan, Wendy M.
Nugent, Ann
Deutscher, Meredith
Masson, Carmen L.
Des Jarlais, Don C.
description Injecting drug users (IDUs) are at high risk for contracting and spreading viral hepatitis through nonsterile injection practices, unprotected sexual contact, and unsanitary living conditions. We sought to characterize hepatitis knowledge, prior testing, and vaccination history among IDUs at a New York City syringe exchange program (SEP). IDU subjects generally had a poor understanding of viral hepatitis transmission and prevention. We also found low vaccination rates: only 8% reported receiving hepatitis A vaccine and 11%, hepatitis B vaccine. Educating IDUs about risky behaviors and medical preventive interventions, such as vaccines for hepatitis A and B and treatment for hepatitis C, may help prevent disease and reduce transmission. Stronger linkages between health-care centers and SEPs, drug treatment programs, and other service delivery centers where IDUs are encountered may promote hepatitis education and vaccination.
doi_str_mv 10.1016/j.jsat.2005.03.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_61368018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0740547205000668</els_id><sourcerecordid>60014542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-8bbf776ae23b41254f367641a041c059959e1e7eaa8b3e3ba0463bfa64e16bd3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhD3BAEQduCTP-iiNxQRVfohIcerccZ7J1tEkWOyn03-OwKyFxoCeP7Gfekedh7CVChYD67VANyS0VB1AViApAPmI7NLUotTTiMdtBLaFUsuYX7FlKAwBwDuYpu0DV1I0SuGPfv07zzwN1eyrmvrilo1vCElLhxnnaF84v4Y6KLq77IkwD-WWO-W0pXJHuY5hyF_3yt24rjnHeRzc-Z096d0j04nxespuPH26uPpfX3z59uXp_XXqFZilN2_Z1rR1x0UrkSvZC11qiA4keVNOohpBqcs60gkSb77Voe6cloW47ccnenGLz2B8rpcWOIXk6HNxE85qsRqENoHkYBECpJH8QxMZIbEBm8PU_4DCvccqftRxrwQWILY2fIB_nlCL19hjD6OK9RbCbPTvYzZ7d7FkQFv4kvzonr-1I3d-Ws64MvDsBlDd7Fyja5ANNnroQsxzbzeF_-b8BTTeqRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217323032</pqid></control><display><type>article</type><title>Knowledge of hepatitis among active drug injectors at a syringe exchange program</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Sociological Abstracts</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><creator>Carey, Jeanne ; Perlman, David C. ; Friedmann, Patricia ; Kaplan, Wendy M. ; Nugent, Ann ; Deutscher, Meredith ; Masson, Carmen L. ; Des Jarlais, Don C.</creator><creatorcontrib>Carey, Jeanne ; Perlman, David C. ; Friedmann, Patricia ; Kaplan, Wendy M. ; Nugent, Ann ; Deutscher, Meredith ; Masson, Carmen L. ; Des Jarlais, Don C.</creatorcontrib><description>Injecting drug users (IDUs) are at high risk for contracting and spreading viral hepatitis through nonsterile injection practices, unprotected sexual contact, and unsanitary living conditions. We sought to characterize hepatitis knowledge, prior testing, and vaccination history among IDUs at a New York City syringe exchange program (SEP). IDU subjects generally had a poor understanding of viral hepatitis transmission and prevention. We also found low vaccination rates: only 8% reported receiving hepatitis A vaccine and 11%, hepatitis B vaccine. Educating IDUs about risky behaviors and medical preventive interventions, such as vaccines for hepatitis A and B and treatment for hepatitis C, may help prevent disease and reduce transmission. Stronger linkages between health-care centers and SEPs, drug treatment programs, and other service delivery centers where IDUs are encountered may promote hepatitis education and vaccination.</description><identifier>ISSN: 0740-5472</identifier><identifier>EISSN: 1873-6483</identifier><identifier>DOI: 10.1016/j.jsat.2005.03.004</identifier><identifier>PMID: 15979531</identifier><identifier>CODEN: JSATEG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject><![CDATA[Adolescent ; Adult ; Aged ; Drug Abuse ; Drug users ; Female ; Health Behavior ; Health Knowledge, Attitudes, Practice ; Hepatitis ; Hepatitis A - prevention & control ; Hepatitis A - transmission ; Hepatitis A Vaccines - administration & dosage ; Hepatitis B - prevention & control ; Hepatitis B - transmission ; Hepatitis B Vaccines - administration & dosage ; Hepatitis C - prevention & control ; Hepatitis C - transmission ; Humans ; Immunization ; Injections ; Knowledge ; Male ; Mass Screening ; Middle Aged ; Needle Exchange Programs ; New York City, New York ; Substance Abuse, Intravenous - epidemiology ; Surveys and Questionnaires ; Syringe exchange ; Tuberculosis - epidemiology ; Vaccination ; Vaccination - statistics & numerical data ; Venereal Diseases]]></subject><ispartof>Journal of substance abuse treatment, 2005-07, Vol.29 (1), p.47-53</ispartof><rights>2005 Elsevier Inc.</rights><rights>Copyright Pergamon Press Inc. Jul 2005</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-8bbf776ae23b41254f367641a041c059959e1e7eaa8b3e3ba0463bfa64e16bd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jsat.2005.03.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,30999,33775,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15979531$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carey, Jeanne</creatorcontrib><creatorcontrib>Perlman, David C.</creatorcontrib><creatorcontrib>Friedmann, Patricia</creatorcontrib><creatorcontrib>Kaplan, Wendy M.</creatorcontrib><creatorcontrib>Nugent, Ann</creatorcontrib><creatorcontrib>Deutscher, Meredith</creatorcontrib><creatorcontrib>Masson, Carmen L.</creatorcontrib><creatorcontrib>Des Jarlais, Don C.</creatorcontrib><title>Knowledge of hepatitis among active drug injectors at a syringe exchange program</title><title>Journal of substance abuse treatment</title><addtitle>J Subst Abuse Treat</addtitle><description>Injecting drug users (IDUs) are at high risk for contracting and spreading viral hepatitis through nonsterile injection practices, unprotected sexual contact, and unsanitary living conditions. We sought to characterize hepatitis knowledge, prior testing, and vaccination history among IDUs at a New York City syringe exchange program (SEP). IDU subjects generally had a poor understanding of viral hepatitis transmission and prevention. We also found low vaccination rates: only 8% reported receiving hepatitis A vaccine and 11%, hepatitis B vaccine. Educating IDUs about risky behaviors and medical preventive interventions, such as vaccines for hepatitis A and B and treatment for hepatitis C, may help prevent disease and reduce transmission. Stronger linkages between health-care centers and SEPs, drug treatment programs, and other service delivery centers where IDUs are encountered may promote hepatitis education and vaccination.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Drug Abuse</subject><subject>Drug users</subject><subject>Female</subject><subject>Health Behavior</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Hepatitis</subject><subject>Hepatitis A - prevention &amp; control</subject><subject>Hepatitis A - transmission</subject><subject>Hepatitis A Vaccines - administration &amp; dosage</subject><subject>Hepatitis B - prevention &amp; control</subject><subject>Hepatitis B - transmission</subject><subject>Hepatitis B Vaccines - administration &amp; dosage</subject><subject>Hepatitis C - prevention &amp; control</subject><subject>Hepatitis C - transmission</subject><subject>Humans</subject><subject>Immunization</subject><subject>Injections</subject><subject>Knowledge</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Middle Aged</subject><subject>Needle Exchange Programs</subject><subject>New York City, New York</subject><subject>Substance Abuse, Intravenous - epidemiology</subject><subject>Surveys and Questionnaires</subject><subject>Syringe exchange</subject><subject>Tuberculosis - epidemiology</subject><subject>Vaccination</subject><subject>Vaccination - statistics &amp; numerical data</subject><subject>Venereal Diseases</subject><issn>0740-5472</issn><issn>1873-6483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>BHHNA</sourceid><recordid>eNqFkU1v1DAQhi0EokvhD3BAEQduCTP-iiNxQRVfohIcerccZ7J1tEkWOyn03-OwKyFxoCeP7Gfekedh7CVChYD67VANyS0VB1AViApAPmI7NLUotTTiMdtBLaFUsuYX7FlKAwBwDuYpu0DV1I0SuGPfv07zzwN1eyrmvrilo1vCElLhxnnaF84v4Y6KLq77IkwD-WWO-W0pXJHuY5hyF_3yt24rjnHeRzc-Z096d0j04nxespuPH26uPpfX3z59uXp_XXqFZilN2_Z1rR1x0UrkSvZC11qiA4keVNOohpBqcs60gkSb77Voe6cloW47ccnenGLz2B8rpcWOIXk6HNxE85qsRqENoHkYBECpJH8QxMZIbEBm8PU_4DCvccqftRxrwQWILY2fIB_nlCL19hjD6OK9RbCbPTvYzZ7d7FkQFv4kvzonr-1I3d-Ws64MvDsBlDd7Fyja5ANNnroQsxzbzeF_-b8BTTeqRg</recordid><startdate>20050701</startdate><enddate>20050701</enddate><creator>Carey, Jeanne</creator><creator>Perlman, David C.</creator><creator>Friedmann, Patricia</creator><creator>Kaplan, Wendy M.</creator><creator>Nugent, Ann</creator><creator>Deutscher, Meredith</creator><creator>Masson, Carmen L.</creator><creator>Des Jarlais, Don C.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>K7.</scope><scope>K9.</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7U4</scope><scope>BHHNA</scope><scope>DWI</scope><scope>WZK</scope><scope>7U3</scope></search><sort><creationdate>20050701</creationdate><title>Knowledge of hepatitis among active drug injectors at a syringe exchange program</title><author>Carey, Jeanne ; Perlman, David C. ; Friedmann, Patricia ; Kaplan, Wendy M. ; Nugent, Ann ; Deutscher, Meredith ; Masson, Carmen L. ; Des Jarlais, Don C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-8bbf776ae23b41254f367641a041c059959e1e7eaa8b3e3ba0463bfa64e16bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Drug Abuse</topic><topic>Drug users</topic><topic>Female</topic><topic>Health Behavior</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Hepatitis</topic><topic>Hepatitis A - prevention &amp; control</topic><topic>Hepatitis A - transmission</topic><topic>Hepatitis A Vaccines - administration &amp; dosage</topic><topic>Hepatitis B - prevention &amp; control</topic><topic>Hepatitis B - transmission</topic><topic>Hepatitis B Vaccines - administration &amp; dosage</topic><topic>Hepatitis C - prevention &amp; control</topic><topic>Hepatitis C - transmission</topic><topic>Humans</topic><topic>Immunization</topic><topic>Injections</topic><topic>Knowledge</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Middle Aged</topic><topic>Needle Exchange Programs</topic><topic>New York City, New York</topic><topic>Substance Abuse, Intravenous - epidemiology</topic><topic>Surveys and Questionnaires</topic><topic>Syringe exchange</topic><topic>Tuberculosis - epidemiology</topic><topic>Vaccination</topic><topic>Vaccination - statistics &amp; numerical data</topic><topic>Venereal Diseases</topic><toplevel>online_resources</toplevel><creatorcontrib>Carey, Jeanne</creatorcontrib><creatorcontrib>Perlman, David C.</creatorcontrib><creatorcontrib>Friedmann, Patricia</creatorcontrib><creatorcontrib>Kaplan, Wendy M.</creatorcontrib><creatorcontrib>Nugent, Ann</creatorcontrib><creatorcontrib>Deutscher, Meredith</creatorcontrib><creatorcontrib>Masson, Carmen L.</creatorcontrib><creatorcontrib>Des Jarlais, Don C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Sociological Abstracts (pre-2017)</collection><collection>Sociological Abstracts</collection><collection>Sociological Abstracts</collection><collection>Sociological Abstracts (Ovid)</collection><collection>Social Services Abstracts</collection><jtitle>Journal of substance abuse treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carey, Jeanne</au><au>Perlman, David C.</au><au>Friedmann, Patricia</au><au>Kaplan, Wendy M.</au><au>Nugent, Ann</au><au>Deutscher, Meredith</au><au>Masson, Carmen L.</au><au>Des Jarlais, Don C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Knowledge of hepatitis among active drug injectors at a syringe exchange program</atitle><jtitle>Journal of substance abuse treatment</jtitle><addtitle>J Subst Abuse Treat</addtitle><date>2005-07-01</date><risdate>2005</risdate><volume>29</volume><issue>1</issue><spage>47</spage><epage>53</epage><pages>47-53</pages><issn>0740-5472</issn><eissn>1873-6483</eissn><coden>JSATEG</coden><abstract>Injecting drug users (IDUs) are at high risk for contracting and spreading viral hepatitis through nonsterile injection practices, unprotected sexual contact, and unsanitary living conditions. We sought to characterize hepatitis knowledge, prior testing, and vaccination history among IDUs at a New York City syringe exchange program (SEP). IDU subjects generally had a poor understanding of viral hepatitis transmission and prevention. We also found low vaccination rates: only 8% reported receiving hepatitis A vaccine and 11%, hepatitis B vaccine. Educating IDUs about risky behaviors and medical preventive interventions, such as vaccines for hepatitis A and B and treatment for hepatitis C, may help prevent disease and reduce transmission. Stronger linkages between health-care centers and SEPs, drug treatment programs, and other service delivery centers where IDUs are encountered may promote hepatitis education and vaccination.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15979531</pmid><doi>10.1016/j.jsat.2005.03.004</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0740-5472
ispartof Journal of substance abuse treatment, 2005-07, Vol.29 (1), p.47-53
issn 0740-5472
1873-6483
language eng
recordid cdi_proquest_miscellaneous_61368018
source MEDLINE; Elsevier ScienceDirect Journals Complete; Sociological Abstracts; Applied Social Sciences Index & Abstracts (ASSIA)
subjects Adolescent
Adult
Aged
Drug Abuse
Drug users
Female
Health Behavior
Health Knowledge, Attitudes, Practice
Hepatitis
Hepatitis A - prevention & control
Hepatitis A - transmission
Hepatitis A Vaccines - administration & dosage
Hepatitis B - prevention & control
Hepatitis B - transmission
Hepatitis B Vaccines - administration & dosage
Hepatitis C - prevention & control
Hepatitis C - transmission
Humans
Immunization
Injections
Knowledge
Male
Mass Screening
Middle Aged
Needle Exchange Programs
New York City, New York
Substance Abuse, Intravenous - epidemiology
Surveys and Questionnaires
Syringe exchange
Tuberculosis - epidemiology
Vaccination
Vaccination - statistics & numerical data
Venereal Diseases
title Knowledge of hepatitis among active drug injectors at a syringe exchange program
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A50%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Knowledge%20of%20hepatitis%20among%20active%20drug%20injectors%20at%20a%20syringe%20exchange%20program&rft.jtitle=Journal%20of%20substance%20abuse%20treatment&rft.au=Carey,%20Jeanne&rft.date=2005-07-01&rft.volume=29&rft.issue=1&rft.spage=47&rft.epage=53&rft.pages=47-53&rft.issn=0740-5472&rft.eissn=1873-6483&rft.coden=JSATEG&rft_id=info:doi/10.1016/j.jsat.2005.03.004&rft_dat=%3Cproquest_cross%3E60014542%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217323032&rft_id=info:pmid/15979531&rft_els_id=S0740547205000668&rfr_iscdi=true